Unaltered susceptibility to BSE in transgenic mice expressing human prion protein

Nature

Volumn 378, Issue 6559, 1995, Pages 779-783

  Collinge, John ^a,b   Palmer, Mark S ^a   Sidle, Katie C L ^a   Hill, Andrew F ^a   Gowland, Ian ^a   Meads, Julie ^a   Asante, Emmanuel ^a   Bradley, Ray ^c   Doey, Lawrence J ^d   Lantos, Peter L ^d  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^b ST MARY S HOSPITAL   (United Kingdom)

^c VETERINARY LABORATORIES AGENCY   (United Kingdom)

^d KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN SPONGIOSIS; CONTROLLED STUDY; DISEASE PREDISPOSITION; DISEASE TRANSMISSION; INCUBATION TIME; MOUSE; NONHUMAN; PRION; PRION DISEASE; PRIORITY JOURNAL; TRANSGENIC MOUSE; HUMAN;

ANIMALS; BRAIN; CATTLE; CREUTZFELDT-JAKOB SYNDROME; DISEASE SUSCEPTIBILITY; ENCEPHALOPATHY, BOVINE SPONGIFORM; HUMANS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; PRIONS; PRPSC PROTEINS; RECOMBINANT PROTEINS; SPECIES SPECIFICITY;

ANIMALIA; BOVINAE; FELIS CATUS; MUS MUSCULUS;

PRION PROTEIN;

EID: 13344293718     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/378779a0     Document Type: Article

References (30)

1. Prusiner, S. B. Science 252, 1515-1522 (1991).
2. Pattison, I. H. in Slow, Latent and Temperate Virus Infections, NINDB Monograph 2 (ed. Gajdusek, C. J., Gibbs, C. J. & Alpers, M. P.) 249-257 (US Government Printing, Washington DC, 1965).
3. Prusiner, S. B. et al. Cell 63, 673-686 (1990).
4. Bruce, M. et al. Phil. Trans. R. Soc. Lond. B 343, 405-411 (1994).
5. Telling, G. C. et al. Proc. natn. Acad. Sei. U.S.A. 91, 9936-9940 (1994).
6. Whittington, M. A. et al. Nature Genet. 9, 197-201 (1995).
7. Brown, P. et al. Ann. Neurol. 35, 513-529 (1994).
8. Poulter, M. et al. Brain 115, 675-685 (1992).
9. Collinge, J. et al. Lancet 346, 569-570 (1995).
10. Büeler, H. et al. Nature 356, 577-582 (1992).
11. Büeler, H. et al. Cell 73, 1339-1347 (1993).
12. Prusiner, S. B. et al. Proc. natn. Acad. Sei. U.S.A. 90, 10608-10612 (1993).
13. Collinge, J. et al. Nature 370, 295-297 (1994).
14. Wells, G. A. H„ Wilesmith, J. W. & Mc Gill, I. S. Brain PathI. 1, 69-78 (1991).
15. Fraser, H., Mc Connell, I., Wells, G. A. H. & Dawson, M. Vet Rec. 123, 472 (1988).
16. Fraser, H., Bruce, M. E., Chree, A., Mc Connell, I. & Wells, G. A. J. gen. Virol. 73, 18911897 (1992).
17. Barlow, R. M. & Middleton, D. J. Vet. Rec. 126, 111-112 (1990).
18. Kimberlin, R. FI. in Transmissible Spongiform Encephalopathies: Proceedings of a Consultation on BSE with the Scientific Veterinary Committee of the Commission of the European Communities held in Brussels from 14 to 15 September 1993 (eds Bradley, R. & Marchant, B.) 455-477 (CEC, Brussels, 1994).
19. Palmer, M. S., Dryden, A. J., Flughes, J. T. & Collinge, J. Nature 352, 340-342 (1991).
20. Collinge, J., Palmer, M. S. & Dryden, A. J. Lancet 337, 1441-1442 (1991).
21. Brown, P. et al. Neurology 44, 291-293 (1994).
22. Baker, H. F. et al. Lancet 337, 1286 (1991).
23. Hsiao, K. et al. Nature Genet. 1, 68-71 (1992).
24. Carlson, G. A. et al. Ceil 46, 503-511 (1986).
25. Kascsak, R. J. et al. J. Virol. 61, 3688-3693 (1987).
26. Serban, D., Taraboulos, A., DeArmond, S. J. & Prusiner, S. B. Neurology 40, 110-117 (1990).
27. Laemmli, U. K. Nature 227, 680-685 (1970).
28. Westaway, D. et al. Cell 76, 117-129 (1994).
29. Taylor, D. M. et al. Archs. Virol. 139, 313-326 (1994).
30. Lantos, P. L. et al. Neurosci. Lett. 147, 67-71 (1992).